Anzhong Li

Title: Anzhong Li: Innovator in Zika Virus Research

Introduction

Anzhong Li is a notable inventor based in Columbus, Ohio, recognized for his contributions to the field of virology, particularly in relation to the Zika virus. His innovative work has led to the development of a patent that addresses critical aspects of Zika virus protein subunits.

Latest Patents

Anzhong Li holds a patent for "Recombinant vectors encoding Zika virus protein subunits." This patent provides compositions, methods, and uses for recombinant vectors that encode Zika virus (ZIKV) protein subunits. The embodiments disclosed include recombinant vectors encoding ZIKV nonstructural protein 1 (NS1), as well as ZIKV envelope (E) protein and premembrane (prM) protein. The patent also details expression cassettes that comprise a promoter operably linked to a polynucleotide encoding the ZIKV NS1 protein, with optional inclusion of ZIKV E and prM proteins. Furthermore, the patent outlines immunogenic compositions and methods for inducing an immune response against ZIKV in subjects.

Career Highlights

Anzhong Li has made significant strides in his career, working at esteemed institutions such as the Research Institute at Nationwide Children's Hospital and the Ohio State Innovation Foundation. His research has focused on developing innovative solutions to combat viral infections, particularly those caused by the Zika virus.

Collaborations

Anzhong Li has collaborated with notable colleagues in his field, including Mark Edward Peeples and Jianrong Li. These collaborations have contributed to the advancement of research and development in virology.

Conclusion

Anzhong Li's work exemplifies the importance of innovation in addressing public health challenges, particularly in the realm of infectious diseases. His contributions to Zika virus research through his patented inventions highlight the critical role of inventors in advancing scientific knowledge and developing effective medical solutions.